- Home
- TRS vs XERS Comparison
TRS vs XERS Comparison
Compare TRS & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRS
- XERS
- Stock Information
- Founded
- TRS 1986
- XERS 2005
- Country
- TRS United States
- XERS United States
- Employees
- TRS N/A
- XERS N/A
- Industry
- TRS Industrial Specialties
- XERS Biotechnology: Pharmaceutical Preparations
- Sector
- TRS Industrials
- XERS Health Care
- Exchange
- TRS Nasdaq
- XERS Nasdaq
- Market Cap
- TRS 1.5B
- XERS 1.3B
- IPO Year
- TRS 2007
- XERS 2018
- Fundamental
- Price
- TRS $39.00
- XERS $7.49
- Analyst Decision
- TRS Strong Buy
- XERS Strong Buy
- Analyst Count
- TRS 2
- XERS 7
- Target Price
- TRS $45.00
- XERS $8.00
- AVG Volume (30 Days)
- TRS 567.0K
- XERS 2.0M
- Earning Date
- TRS 11-03-2025
- XERS 11-07-2025
- Dividend Yield
- TRS 0.41%
- XERS N/A
- EPS Growth
- TRS N/A
- XERS N/A
- EPS
- TRS 0.91
- XERS N/A
- Revenue
- TRS $973,840,000.00
- XERS $246,025,000.00
- Revenue This Year
- TRS $11.03
- XERS $43.89
- Revenue Next Year
- TRS $6.13
- XERS $20.40
- P/E Ratio
- TRS $42.91
- XERS N/A
- Revenue Growth
- TRS 6.72
- XERS 35.62
- 52 Week Low
- TRS $19.33
- XERS $2.69
- 52 Week High
- TRS $39.71
- XERS $8.03
- Technical
- Relative Strength Index (RSI)
- TRS 64.11
- XERS 55.56
- Support Level
- TRS $37.85
- XERS $7.56
- Resistance Level
- TRS $39.71
- XERS $7.89
- Average True Range (ATR)
- TRS 0.92
- XERS 0.24
- MACD
- TRS -0.21
- XERS -0.12
- Stochastic Oscillator
- TRS 65.87
- XERS 13.60
About TRS TriMas Corporation
TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).